CTM Biomedical

Focus: CTM Biomedical is a Toronto-based medical device company founded in 2021 specializing in connective tissue implants for orthopedic and musculoskeletal applications. The company operates as an early-stage innovator in a narrow but high-value surgical implant market.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About CTM Biomedical

AI assessmentNot Hiring

No open roles listed right now. Follow CTM Biomedical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

CTM

Osteoarthritis

N/A

Clinical Trials (1)

NCT06171529Efficacy of a Single Injection of CTM for Post-Operative CMC Arthritis

N/A

Help build intelligence for CTM Biomedical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Founding-stage opportunity (2021) to shape organizational culture and establish career trajectory in an emerging medical device company
Focus on connective tissue implants addresses high-prevalence orthopedic conditions (rotator cuff, osteoarthritis, tennis elbow) with established clinical demand
Early pipeline with 6 programs across Phase 1-2 suggests active development and potential for multiple clinical inflection points

Watch Out For

Pre-revenue stage with no disclosed funding, cash position, or employee count raises sustainability and growth capital questions
No active job openings (0 open roles) suggests minimal near-term hiring and potential resource constraints
Early pipeline shows no Phase 3 programs and lacks published clinical data (0 publications), indicating nascent development stage with extended path to commercialization

Generated by Claude from CTM Biomedical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

celgene

Rotator Cuff Tendinopathy

N/A

Clinical Trials (1)

NCT06712290Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy

N/A

Rotator Cuff Repair with Allograft Patch

Rotator Cuff Tear

N/A

Clinical Trials (1)

NCT07027735Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation

N/A

Extracellular Matrix Graft Injectable Implant

Arthroscopic Shoulder Surgery

N/A

Clinical Trials (1)

NCT04633837Examining the Effectiveness of a Connective Tissue Matrix Implant in Reducing Post-operative Pain and Narcotic After Outpatient Arthroscopic Shoulder Surgery

N/A

CTM Injection

Osteoarthritis Shoulder

Phase 1

Clinical Trials (1)

NCT06171542Efficacy of a Single Image Guided Injection of CTM for Glenohumeral Arthritis

Phase 1

CTM

Tennis Elbow

Phase 2

Clinical Trials (1)

NCT06171555Efficacy of CTM for Tennis ELbow

Phase 2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2021

Portfolio: 6 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo